Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer : a Prospective, Single-arm, Open-label Study
Latest Information Update: 28 Sep 2023
At a glance
- Drugs Pyrotinib (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer; Brain metastases
- Focus Therapeutic Use
- 03 May 2019 New trial record